Harvard Bioscience Inc (HBIO)
Sector • Healthcare Industry • Laboratory Analytical Instruments |
Industry • Laboratory Analytical Instruments |
Sector • Healthcare |
News
Harvard Bioscience Inc Reports Mixed Results in Fourth Quarter of 20232.
Harvard Bioscience Inc. Reports a Deficit of $0.03 per Share and Decreased Revenue in Q3 2023
Harvard Bioscience Inc Faces Revenue Slump in Fiscal Q2 2023
A modest 4.159%, rise in revenue at Harvard Bioscience Inc over the fiscal first quarter of 2023
The company has Turned into Profitability at HBIO during the most recent fiscal period
The Deficit has enlarged more at the company during the fiscal first quarter of 2022